Decoy Therapeutics Inc.
DCOY | NASDAQ
$1.07
-$0.16 (-13.01%)
At close: Oct 30, 2026, 4:00 PM ET
$1.13
+$0.06 (+5.61%)
Pre-market:
Nov 2, 2026, 7:02 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.84M | n/a | 571.39K | 1.27M |
Cost of Revenue | n/a | n/a | 8.52M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | -8.52M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.84M | n/a | 571.39K | 1.27M |
Operating Income | -2.63M | -2.28M | -9.03M | -895.13K | -965.57K | -1.72M | -1.49M | -1.01M | -1.47M | -1.77M | -970.7K | -2.53M | -3.97M | -5.42M | -6.48M | -5.62M | -4.76M | -6.12M | -4.14M | -3.75M | -3.12M | -1.8M |
Interest Income | 29.59K | 59.11K | -38.57K | 21.66K | 7.74K | 9.16K | 24.78K | 34.35K | 43.08K | 56.33K | 88.91K | 89.37K | 94.09K | 79.89K | 105.06K | 78.61K | 39.63K | 8K | n/a | 487 | 265 | n/a |
Pretax Income | -2.37M | -2.22M | -8.98M | -873.47K | -957.83K | -1.71M | -1.46M | -972.12K | -1.42M | -1.72M | -881.8K | -2.44M | -3.88M | -5.34M | -6.37M | -14.41M | -4.72M | -6.11M | -4.1M | -3.74M | -3.07M | -1.85M |
Net Income | -2.37M | -2.22M | -8.98M | -873.47K | -957.83K | -1.71M | -1.46M | -972.12K | -1.42M | -1.72M | -881.8K | -2.44M | -3.88M | -5.34M | -6.37M | -14.41M | -4.72M | -6.11M | -4.1M | -3.74M | -3.07M | -1.85M |
Selling & General & Admin | 1.33M | 1.53M | 403.27K | 833.3K | 849.18K | 1.64M | 1.31M | 869.24K | 1.25M | 1.53M | 910.75K | 1.5M | 1.62M | 1.7M | 1.79M | 1.83M | 1.84M | 1.68M | 1.45M | 1.73M | 1.59M | 1.33M |
Research & Development | 1.3M | 749.81K | 114.43K | 61.83K | 116.38K | 75.53K | 175.34K | 137.23K | 214.45K | 243K | 59.95K | 1.04M | 2.35M | 3.73M | 4.69M | 3.79M | 2.92M | 4.44M | 2.7M | 2.02M | 2.1M | 1.74M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.84M | n/a | n/a | n/a |
Operating Expenses | 2.63M | 2.28M | 517.7K | 895.13K | 965.57K | 1.72M | 1.49M | 1.01M | 1.47M | 1.77M | 970.7K | 2.53M | 3.97M | 5.42M | 6.48M | 5.62M | 4.76M | 6.12M | 2.3M | 3.75M | 3.69M | 3.07M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.25K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.63M | 2.28M | 9.03M | 895.13K | 965.57K | 1.72M | 1.49M | 1.01M | 1.47M | 1.77M | 970.7K | 2.53M | 3.97M | 5.42M | 6.48M | 5.62M | 4.76M | 6.12M | 2.3M | 3.75M | 3.69M | 3.07M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 531.97K | 531.97K | 481.59K | 481.59K | 141.52K | 110.93K | 96.08K | 85.46K | 40.03K | 34.96K | 32.82K | 31.28K | 22.58K | 19.93K | 18.78K | 18.73K | 17.84K | 15.5K | 15.08K | 14.93K | 14.92K | 10.92K |
Shares Outstanding (Diluted) | 531.97K | 531.97K | 481.59K | 481.59K | 141.52K | 110.93K | 96.08K | 85.46K | 40.03K | 34.96K | 32.82K | 31.28K | 22.58K | 19.93K | 18.78K | 18.73K | 17.84K | 15.5K | 15.08K | 14.93K | 14.92K | 10.92K |
EPS (Basic) | -4.46 | -4.18 | -18.64 | -1.81 | -6.77 | -15.41 | -15.24 | -11.38 | -35.59 | -49.07 | -26.87 | -78.09 | -171.75 | -267.94 | -339.25 | -769.26 | -264.48 | -394.26 | -272.28 | -250.23 | -206.07 | -169.54 |
EPS (Diluted) | -4.46 | -4.18 | -18.64 | -1.81 | -6.77 | -15.41 | -15.24 | -11.38 | -35.59 | -49.07 | -26.87 | -78.09 | -171.75 | -267.94 | -339.25 | -769.26 | -264.48 | -394.26 | -272.28 | -250.23 | -206.07 | -169.54 |
EBITDA | -2.37M | -2.22M | -8.97M | -872.36K | -956.72K | -1.71M | -1.46M | -971.02K | -1.42M | -1.71M | -880.69K | -2.44M | -3.88M | -5.34M | -6.37M | -14.41M | -4.72M | -6.1M | -4.1M | -3.73M | -3.07M | -1.8M |
EBIT | -2.37M | -2.22M | -8.98M | -873.47K | -957.83K | -1.71M | -1.46M | -972.12K | -1.42M | -1.72M | -881.8K | -2.44M | -3.88M | -5.34M | -6.37M | -14.41M | -4.72M | -6.11M | -4.1M | -3.74M | -3.07M | -1.8M |
Depreciation & Amortization | n/a | 5.92K | 3.83K | 1.11K | 1.11K | 1.11K | 1.11K | 1.11K | 1.11K | 1.11K | 1.11K | 5.61K | 1.67K | 1.67K | 1.67K | 1.67K | -1.46K | 4.8K | 4.8K | 4.8K | 4.8K | 4.8K |
Add to Watchlist
Select watchlists to add or remove DCOY